RadNet Shares Outstanding 2010-2024 | RDNT

RadNet shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
RadNet Annual Shares Outstanding
(Millions of Shares)
2023 65
2022 57
2021 53
2020 51
2019 50
2018 49
2017 47
2016 47
2015 45
2014 43
2013 40
2012 39
2011 39
2010 37
2009 36
RadNet Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 75
2024-06-30 73
2024-03-31 69
2023-12-31 65
2023-09-30 69
2023-06-30 61
2023-03-31 58
2022-12-31 57
2022-09-30 58
2022-06-30 57
2022-03-31 56
2021-12-31 53
2021-09-30 54
2021-06-30 53
2021-03-31 53
2020-12-31 51
2020-09-30 52
2020-06-30 51
2020-03-31 50
2019-12-31 50
2019-09-30 50
2019-06-30 50
2019-03-31 50
2018-12-31 49
2018-09-30 49
2018-06-30 49
2018-03-31 48
2017-12-31 47
2017-09-30 48
2017-06-30 47
2017-03-31 47
2016-12-31 47
2016-09-30 46
2016-06-30 47
2016-03-31 47
2015-12-31 45
2015-09-30 45
2015-06-30 45
2015-03-31 43
2014-12-31 43
2014-09-30 44
2014-06-30 43
2014-03-31 40
2013-12-31 40
2013-09-30 39
2013-06-30 40
2013-03-31 39
2012-12-31 39
2012-09-30 40
2012-06-30 39
2012-03-31 38
2011-12-31 39
2011-09-30 38
2011-06-30 40
2011-03-31 37
2010-12-31 37
2010-09-30 37
2010-06-30 37
2010-03-31 36
2009-12-31 36
2009-09-30 36
2009-06-30 36
2009-03-31 36
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $4.972B $1.617B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.703B 0.00
Quest Diagnostics (DGX) United States $17.349B 17.58
DaVita (DVA) United States $14.249B 18.43
Encompass Health (EHC) United States $9.629B 22.70
Chemed (CHE) United States $8.394B 25.80
Elanco Animal Health (ELAN) United States $6.076B 14.46
Option Care Health (OPCH) United States $5.267B 24.96
LifeStance Health (LFST) United States $3.092B 0.00
Amedisys (AMED) United States $3.023B 21.51
Addus HomeCare (ADUS) United States $2.290B 26.87
Astrana Health (ASTH) United States $2.076B 28.39
U.S Physical Therapy (USPH) United States $1.337B 35.14
Pennant (PNTG) United States $0.945B 38.21
Aveanna Healthcare Holdings (AVAH) United States $0.945B 0.00
Atai Life Sciences (ATAI) Germany $0.252B 0.00
Bioqual (BIOQ) United States $0.055B 0.00
Daxor (DXR) United States $0.038B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00